Apixaban for thromboprophylaxis post-discharge causes bleeding (ADOPT Trial, NEJM)
www.pulmccm.org
For years, Pharma have been itching to prove a benefit of extended chemoprophylaxis against DVT / PE in medically ill patients after hospital discharge.
Apixaban for thromboprophylaxis post-discharge causes bleeding (ADOPT Trial, NEJM)
Apixaban for thromboprophylaxis…
Apixaban for thromboprophylaxis post-discharge causes bleeding (ADOPT Trial, NEJM)
For years, Pharma have been itching to prove a benefit of extended chemoprophylaxis against DVT / PE in medically ill patients after hospital discharge.